Type 2 diabetes increases an individual’s risk of Cardiovascular Disease (CVD). Trials have demonstrated the long term macro-vascular benefits of lowering glucose, as well as other CVD risk factors, in populations with established diabetes.
Purpose There is a need for information on the Health Related Quality of Life (HRQoL) of injury populations. HRQoL measures, like the EQ-5D, have seen a dramatic increase in use over the last ten years. Despite this, general information on HRQoL …